Agent-specific, histopathology-stratified hematologic malignancy risk among dpp-4 inhibitors, glp-1 receptor agonists, and SGLT2 inhibitors: a network meta-analysis of 270,471 participants
DPP-4抑制剂、GLP-1受体激动剂和SGLT2抑制剂的药物特异性、组织病理学分层血液系统恶性肿瘤风险：一项纳入270,471名参与者的网络荟萃分析
期刊:Journal of Hematology & Oncology
影响因子:40.4
doi:10.1186/s13045-026-01788-5
Lin, Pao-Yen; Zeng, Bing-Syuan; Chen, Jiann-Jy; Zeng, Bing-Yan; Suen, Mein-Woei; Hung, Chao-Ming; Hsu, Chih-Wei; Stubbs, Brendon; Chen, Yen-Wen; Chen, Tien-Yu; Lei, Wei-Te; Hsu, Shih-Pin; Shiue, Yow-Ling; Su, Kuan-Pin; Li, Cheng-Ta; Wang, Hung-Yu; Tseng, Ping-Tao; Liang, Chih-Sung
